Curaleaf Holdings Inc
CURA: XTSE (CAN)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CAD 87.60 | Qqnq | Plnfvmr |
Curaleaf Delays Fourth-Quarter and Fiscal-Year 2022 Earnings Release
Curaleaf’s fourth-quarter and full-year 2022 earnings release was originally set for March 28. On March 24, the company announced a delay until some date in April, yet to be announced. The company cited complexities with converting to U.S. GAAP from IFRS reporting standards as the main reason for the delay.